2019 ASCO Annual Meeting Highlights for the Advanced Practitioner: Melanoma

In recent years, there has been an explosion of therapies for the treatment of melanoma, including BRAF mutation–guided therapy. With coverage by The ASCO Post, Lisa Kottschade, APRN, MSN, CNP, of the Mayo Clinic reviews clinical data supporting emerging targeted therapies and immunotherapies, and s...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2019
Materias:
Meeting Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520731/
https://www.ncbi.nlm.nih.gov/pubmed/33364070
http://dx.doi.org/10.6004/jadpro.2019.10.6.8
Descripción
Sumario:In recent years, there has been an explosion of therapies for the treatment of melanoma, including BRAF mutation–guided therapy. With coverage by The ASCO Post, Lisa Kottschade, APRN, MSN, CNP, of the Mayo Clinic reviews clinical data supporting emerging targeted therapies and immunotherapies, and shares considerations on patient selection, education, and adverse event management.

Ejemplares similares